問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital

Division of General Internal Medicine

更新時間:2024-02-21

張立群
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

13Cases

2025-11-14 - 2029-06-30

Phase I

Not yet recruiting
A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors
  • Condition/Disease

    NSCLC Adenocarcinoma

  • Test Drug

    錠劑 膠囊劑 錠劑

Participate Sites
4Sites

Recruiting4Sites

2026-03-30 - 2032-08-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting3Sites

Recruiting2Sites

2026-06-01 - 2029-12-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

2026-03-16 - 2031-11-30

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2026-06-01 - 2028-07-30

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting5Sites

2026-03-16 - 2029-01-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Not yet recruiting2Sites

Recruiting10Sites

2025-11-01 - 2033-12-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting9Sites

2023-12-01 - 2026-12-31

Phase II/III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting5Sites

2026-07-14 - 2031-05-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Not yet recruiting2Sites

2026-04-01 - 2029-11-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting6Sites

1 2